The Biology Committee (BC) provides various activities at the educational and research level to foster and promote basic, preclinical and translational / clinical biology within European radiation oncology. To fulfil this aim, the BC activities are focused on:

• Promoting international exchange of knowledge and experience and supporting international as well as national activities to establish graduate and postgraduate training programmes in the field of radiation research in general, especially in basic and clinical radiation biology/oncology;
• Serving as advisory committee to the Scientific Committee at the annual ESTRO meeting and responsibility for appointing a biologist to the Programme Committee of this meeting;
• Providing topics for pre-meeting activities and biology sessions at the annual ESTRO meeting;
• Appointing a member of the Biology Committee to become member of the ESTRO Education Council;
• Advising the ESTRO Education Council in establishing new teaching courses and appointing new course directors;
• The Biology Committee meets twice a year: at the ESTRO office and at the annual conference.

 

17th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology, Hurdalsjøen, Norway, 21-23 June, 2025

Announcement and Call for Abstracts

Dear Colleague,

The organisers of the 17th International Wolfsberg Meeting on Molecular Radiation Biology/ Oncology 2025 are pleased to draw your attention to this high-profile meeting and to invite your abstract application. The meeting will be held – for the second time – in Hurdalsjøen Hotel, Norway, which is a similar setting to that used before, Wolfsberg Castle, as it is surrounded by nature. The meeting will cover basic mechanisms and clinical perspectives of the four most relevant cutting-edge topics of molecular radiation biology/oncology:

​Session I “DNA Repair” (Saturday afternoon/evening session)

Session II “Intra- and Inter-cellular Signalling” (Sunday morning session)

Session III “Microenvironment” (Sunday afternoon session)

Session IV “Novel Therapies and Biomarkers” (Monday morning session)

A Keynote Lecture by Douglas Green (St. Jude Children’s Research Hospital, Memphis, USA) will open the conference. Each of the four sessions will be started with either one or two Invited Lectures, which will be presented by internationally leading scientists (session I: Evi Soutoglou, UK; session II: Lara Barazzuol, The Netherlands / Daniel Wahl, USA; session III: Tim Illidge, UK / Monica Olcina, UK; session IV: Costas Koumenis, USA / Jason Holland, Switzerland). Poster presentations and proffered paper talks will cover the broad spectrum of research that is performed in each field. The aim of the Wolfsberg Meeting is to present a platform for intensive scientific discussion in a stimulating and friendly atmosphere. Details can be found at www.wolfsberg-oslo-radiation.com.

Proffered papers and posters can be accepted from a maximum of 150 authors.. These participants will be selected through the evaluation of the abstracts by the Scientific Committee. The abstracts are anonymised, so that this evaluation is based just on the scientific quality and innovation aspects of the papers.

The conference fee for the meeting is 9000 NOK (765 |Euros). This fee includes the two-day full-board stay at the Hurdalsjøen Hotel, transport from and to the airport in Oslo and all conference-related costs. The fee must be paid after acceptance of the submitted abstract for poster or proffered paper presentation. Only one abstract per presenting author can be submitted. Details for final registration and payment instructions will follow.

The organisers would like to invite you to send your abstract application describing your most interesting and significant current research in one of the four topics. For abstract submission, it is important to follow the instructions provided on www.wolfsberg-oslo-radiation.com.

Deadline for abstract submission is 31 January, 2025.

Abstracts that are selected for presentation either as proffered paper talks or posters and that fit the scope of the journal Radiotherapy & Oncology may be considered for publication as an original article after peer review. Details for manuscript preparation and submission will be forwarded to the selected authors with information on abstract acceptance as a proffered paper talk or poster.

Please forward this information to your colleagues and co-workers. We are very much looking forward to your abstract application.

With best personal regards,

Ludwig Dubois | Maastricht The Netherlands

Heidi Lyng | Oslo, Norway 

Martin Pruschy | Zurich Switzerland 

Randi Syljuåsen | Oslo, Norway